These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness. Hunter N, Charles MW. J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224 [Abstract] [Full Text] [Related]
7. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA. Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272 [Abstract] [Full Text] [Related]
8. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons. Sasaki MS, Endo S, Ejima Y, Saito I, Okamura K, Oka Y, Hoshi M. Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767 [Abstract] [Full Text] [Related]
9. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors. Kellerer AM, Rühm W, Walsh L. Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103 [Abstract] [Full Text] [Related]